TickerFacts.

Aibotics, Inc. (AIBT): Revenue

Annual figures by period end, from SEC filings.

$2.2K
Year ended 2025-12-31
$0
Trailing 12 months to 2026-06-30
2018-12-31: $02019-12-31: $02024-12-31: $02025-12-31: $2.2K$2.2K
2018-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$2.2Kn/a2026-04-15, From 2025-01-01
2024-12-31$0n/a2026-04-15, From 2024-01-01
No annual figure between 2019-12-31 and 2024-12-31.
2019-12-31$0n/a2020-03-30, From 2019-01-01
2018-12-31$0n/a2020-03-30, From 2018-01-01

Revenue at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Aibotics, Inc. (AIBT)2025-12-31$2.2Kn/a
Nutra Pharma Corp (NPHC)2025-12-31$257.6K+4.6%
China Foods Holdings Ltd. (CFOO)2025-12-31$327.9K+40.5%
Adia Nutrition, Inc. (ADIA)2025-12-31$700.5Kn/m
TFA Therapeutics, Inc. (RAJAF)2025-12-31$1.25M-0.6%
Target Group Inc. (CBDY)2025-12-31$3.88M-41.1%
Healthy Extracts Inc. (HYEX)2025-12-31$4.51M+44.9%
Functional Brands Inc. (MEHA)2025-12-31$6.61M+0.7%
Bon Natural Life Ltd (BON)2025-09-30$18.67M-21.7%

Compare AIBT, NPHC, CFOO, ADIA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗